AppointmentsNew Board Appointments At CBD Firm Voyager

New Board Appointments At CBD Firm Voyager


SCOTTISH CBD firm Voyager has announced three key appointments as it targets fresh distribution channels for its popular range of products and prepares to list on the pan-European Aquis Growth Market in June.

The Perth-based firm set-up in November 2020 by former Zoetic International CEO Nick Tulloch, has appointed two new non-executive directors and a head of sales.

Jill Overland and Nikki Cooper will shortly join the board, while Mark Underwood as head of sales has been charged with finding new outlets for Voyager’s CBD and hemp seed oil products, which are available through its own online portal and more than 20 third-party websites.

Nikki Cooper

Ms Overland has more than 25 years’ experience working in senior finance roles and is currently responsible for finance and corporate services at Cuadrilla. 

Ms Cooper is a qualified solicitor and chartered company secretary, whose career to date has spanned multiple roles, including as a general counsel at Ora Capital Partners, and in corporate finance at N+1 Brewin. 

She also founded her own health supplement brand, Inner Me Limited, following her diagnosis with multiple sclerosis in 2009. The brand successfully gained entry into major retailers, including Boots, Holland and Barrett, Selfridges, Ocado, and on the free-to-air television shopping channel QVC.

Mr Underwood has spent most of his career implementing sales strategies for several blue-chip companies, and was most recently UK sales director in a firm specialising in the CBD market  in the health and wellbeing industry. 

Voyager chairman, Eric Boyle, said the appointments “reflect our robust approach to assurance and compliance as the strong foundations upon which we are building the brand and the business.”

In February, Voyager raised £874,000 through an oversubscribed crowdfunding campaign on Seedrs, and a further £741,000 in April through a private fundraise, including a commitment of £100,000 from Greencare Capital plc, the Aquis-listed investment company focused on medicinal cannabis and related areas.

Jill Overland

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Tilray’s Medical Cannabis Product Now Available And Reimbursed Under Ireland’s Medical Cannabis Access Program

PRESS RELEASE TILRAY Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and...

Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses

AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies...

MGC Pharma Announces Appointment Of UK Advisor And New COO/Deputy CEO

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based bio-pharma company specialising in the production and development...

Sanity Group’s Record Funding Round Led By BAT Could Bring More Big-Tobacco Capital To Cannabis, But Concerns Remain Over Conflicts Of Interest

LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total...

European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos

FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE),...

German SPD Representatives Confident A Solution To International Legal Hurdles Will Be Found

EARLIER this month news broke that recent analysis conducted by the Bundestag's scientific service suggested the creation of a...

Must read

You might also likeRELATED
Recommended to you